CASI Pharmaceuticals (CASIF) Inventory Average (2024 - 2025)

CASI Pharmaceuticals (CASIF) reported Inventory Average of $2.1 million for Q4 2025, down 29.94% quarter-over-quarter from $3.0 million in Q3 2025.

CASI Pharmaceuticals (CASIF) Inventory Average (2024 - 2025) Analysis & Trends

CASI Pharmaceuticals has reported Inventory Average for 2 years, with the latest figure at $2.1 million in Q4 2025.

For the quarter ending Q4 2025, Inventory Average changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (changed N/A YoY), and the FY2025 full-year result was $3.4 million, down 99.96% from the prior year.
Inventory Average for Q4 2025 stood at $2.1 million, down from $3.0 million in the prior quarter.
The five-year high for Inventory Average was $7.9 billion in Q1 2024, with the low at $2.1 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Alterity Therapeutics	860,679.92 Bn	860,679.89 Bn	-	-
2	Belite Bio	55,284.00 Bn	55,284.00 Bn	-	-
3	Quantum Biopharma	16,206.94 Bn	16,206.93 Bn	-	-
4	Legend Biotech	3,318.00 Bn	3,317.71 Bn	242.10 Mn	30.59 Mn
5	Akari Therapeutics	1,543.84 Bn	1,543.84 Bn	-	-
6	Evaxion A	1,449.11 Bn	1,449.09 Bn	-	-
7	Psyence Biomedical	216.99 Bn	216.98 Bn	-	-
8	Vertex Pharmaceuticals	115.22 Bn	107.97 Bn	2.59 Bn	1.73 Bn
9	Abivax	90.58 Bn	90.58 Bn	-	-
10	CASI Pharmaceuticals	-	-	3.69 Mn	2.10 Mn

Download Data